Literature DB >> 20798981

Preparation of immunoglobulin Y (IgY) against lipopolysaccharide using gel chromatography from the yolks of eggs laid by immunized hens.

Siyuan Ma1, Yaping Zhang.   

Abstract

The objective is to prevent and treat injuries caused by lipopolysaccharide (LPS) from gram negative bacteria in animals and humans, we produced antibodies against LPS from egg yolk. LPS from E. coli (O111:B4) mixed with Freund's Adjuvant was used as the immunogen to immunize Roman hens. Immunized eggs were collected, and immunoglobulin Y (IgY) was purified using a water solution, salt precipitation and gel chromatography. The molecular weight and purity were determined by SDS-PAGE, the antibody titer by noncompetitive enzyme-linked immunosorbent assay (ELISA) and antibody activity against LPS by the mortality of mice intraperitoneally injected with LPS or LPS-IgY solutions. IgY against LPS showed two protein bands at 68 and 26 kDa on the gel; the antibody titer was almost 1:25,600. After incubation with LPS, IgY decreased the mortality of mice challenged with LPS. This study provided an efficient way to produce high-titer egg yolk antibodies, which could attenuate lethal effects of LPS, by immunizing hens. Furthermore, the LPS antibody was purified well using a water solution, salting-out and gel chromatography.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20798981     DOI: 10.1007/s10930-010-9275-z

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  20 in total

1.  Development of process to produce polyvalent IgY antibodies anti-African snake venom.

Authors:  Cláudia Maria Costa de Almeida; Cláudia Letícia da Silva; Humberto Pena Couto; Rita de Cássia Mothé Escocard; David Gitirana da Rocha; Lynna de Paula Sentinelli; Thereza Liberman Kipnis; Wilmar Dias da Silva
Journal:  Toxicon       Date:  2008-06-13       Impact factor: 3.033

2.  Passive protection of shrimp against white spot syndrome virus (WSSV) using specific antibody from egg yolk of chickens immunized with inactivated virus or a WSSV-DNA vaccine.

Authors:  Yanan Lu; Junjun Liu; Liji Jin; Xiaoyu Li; Yuhong Zhen; Hongyu Xue; Jiansong You; Yongping Xu
Journal:  Fish Shellfish Immunol       Date:  2008-09-04       Impact factor: 4.581

3.  Preliminary study on treatment of septic shock patients with antilipopolysaccharide IgG from blood donors.

Authors:  A Fomsgaard; L Baek; J S Fomsgaard; A Engquist
Journal:  Scand J Infect Dis       Date:  1989

4.  Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils.

Authors:  Sachiko Nomura; Hidekazu Suzuki; Tatsuhiro Masaoka; Kumiko Kurabayashi; Hiromasa Ishii; Masaki Kitajima; Kikuo Nomoto; Toshifumi Hibi
Journal:  Helicobacter       Date:  2005-02       Impact factor: 5.753

5.  Adhesion and growth inhibitory effect of chicken egg yolk antibody (IgY) on Salmonella enterica serovars Enteritidis and Typhimurium in vitro.

Authors:  Raja Chalghoumi; André Théwis; Yves Beckers; Christopher Marcq; Daniel Portetelle; Yves-Jacques Schneider
Journal:  Foodborne Pathog Dis       Date:  2009-06       Impact factor: 3.171

6.  Anti-lipopolysaccharide immunotherapy in management of septic shock of obstetric and gynaecological origin.

Authors:  E Lachman; S B Pitsoe; S L Gaffin
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

7.  A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides.

Authors:  F E Di Padova; H Brade; G R Barclay; I R Poxton; E Liehl; E Schuetze; H P Kocher; G Ramsay; M H Schreier; D B McClelland
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  In vitro reactivity and growth inhibition of EPEC serotype O111 and STEC serotypes O111 and O157 by homologous and heterologous chicken egg yolk antibody.

Authors:  José Araujo Amaral; Milene Tino De Franco; Lucy Zapata-Quintanilla; Solange Barros Carbonare
Journal:  Vet Res Commun       Date:  2007-12-11       Impact factor: 2.459

9.  Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects.

Authors:  Alan S Cross; Steven M Opal; John E Palardy; Joseph J Drabick; H Shaw Warren; Christian Huber; Pamela Cook; Apurba K Bhattacharjee
Journal:  Vaccine       Date:  2003-11-07       Impact factor: 3.641

10.  Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis.

Authors:  A K Bhattacharjee; S M Opal; J E Palardy; J J Drabick; H Collins; R Taylor; A Cotton; A S Cross
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

View more
  2 in total

1.  Anti-lipopolysaccharide egg yolk antibodies enhance the phagocytosis of mammalian phagocytes.

Authors:  Xin Zhou; Siyuan Ma
Journal:  Biol Open       Date:  2018-06-20       Impact factor: 2.422

2.  Intact anti-LPS IgY is found in the blood after intragastric administration in mice.

Authors:  Xin Zhou; Pei Wang; Yajie Chen; Si-Yuan Ma
Journal:  FEBS Open Bio       Date:  2019-01-30       Impact factor: 2.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.